peripher-kerat--itisulcer- — Inflammatory destruction of the peripheral cornea (immune-mediated corneal melt at the limbus)
Peripheral ulcerative keratitis (PUK) is a rare but sight- and life-threatening inflammatory disorder of the juxtalimbal cornea — the narrow zone of peripheral cornea immediately adjacent to the limbus — characterized by its hallmark triad of epithelial defects, progressive stromal lysis, and a crescent-shaped (arcuate) zone of corneal thinning that advances centrally if untreated and can result in corneal perforation; the underlying pathophysiology centers on the unique anatomy of the peripheral cornea, where limbal capillary arcades allow high-molecular-weight immune complexes (IgM, C1 complement component) to deposit in the corneal stroma, triggering complement activation → chemotaxis of neutrophils and macrophages → release of collagenases, matrix metalloproteinases (MMP-2, MMP-9), and proteases that literally dissolve corneal stroma; the most important clinical context is its strong association with systemic autoimmune disease — approximately 34-42% of cases are associated with rheumatoid arthritis, with granulomatosis with polyangiitis (GPA/Wegener’s), systemic lupus erythematosus, relapsing polychondritis, polyarteritis nodosa, and inflammatory bowel disease accounting for most of the remainder; critically, when PUK occurs in a patient with RA, it signals systemic vasculitis with significantly elevated morbidity and 10-year mortality — making PUK both an ophthalmologic and systemic emergency requiring immediate rheumatology co-management; the idiopathic subset with no identifiable systemic etiology is termed Mooren’s ulcer, which by definition is a diagnosis of exclusion; incidence is estimated at approximately 3 per million per year.
greeklatin
• peripher-: Greek periphereia (περιφέρεια) = “carrying around, circumference, periphery” (from peri- = around + pherein = to carry); refers to the outer boundary of the cornea near the limbus.
• kerat-: Greek keras (κέρας) = “horn” → applied to the cornea because of its tough, horn-like translucent structure.
• ulcer-: Latin ulcus (genitive ulceris) = “a sore, an open wound”; implies a defect with tissue breakdown extending into the stroma.
• -itis: Greek -itis = “inflammation of”; denotes an active inflammatory process.
• Literal: “Inflammation and ulceration of the peripheral cornea” — a composite anatomical and pathological descriptor coined in 20th-century corneal subspecialty literature to distinguish this limbus-adjacent destructive inflammatory process from central corneal ulcers and from non-ulcerative peripheral keratitis.
Classification Table
Type
Etiology
Key Features
RA-associated PUK
Rheumatoid arthritis (most common; 34-42%)
Signals systemic vasculitis; high mortality risk; bilateral in advanced disease
GPA-associated PUK
Granulomatosis with polyangiitis (Wegener’s)
May be presenting feature in up to 60%; often with necrotizing scleritis; poor visual prognosis
SLE-associated PUK
Systemic lupus erythematosus
Associated with systemic flares; sclerokeratitis common
Life-threatening red flag: PUK in RA patient = likely systemic vasculitis → associated 10-year mortality significantly elevated; mandatory systemic workup and rheumatology referral
Related Terms
limbus — the corneoscleral border; the anatomic site of PUK; limbal capillary arcades are the site of immune complex deposition
Mooren’s ulcer — idiopathic PUK; diagnosis of exclusion when all systemic causes excluded; H16.081-H16.083
keratitis — general inflammation of cornea; PUK is a specific subtype targeting the peripheral zone; broad parent code H16
scleritis — inflammation of the sclera; frequently co-occurs with PUK, especially in GPA and RA; necrotizing scleritis + PUK = vasculitic emergency; H15.0x
episcleritis — superficial scleral inflammation; milder than scleritis; distinct but related differential; H15.10-H15.12
rheumatoid arthritis — most common systemic association (~34-42% of PUK); M05.x/M06.x
granulomatosis with polyangiitis (GPA) — second most common; PUK may be presenting sign; M31.30/M31.31
rituximab — anti-CD20 biologic; used for maintenance therapy in GPA-associated and refractory PUK; HCPCS J9312
Clinical Details
Assessment: Slit-lamp exam showing crescent-shaped epithelial defect + stromal thinning at peripheral cornea adjacent to limbus; fluorescein staining delineates epithelial defect; corneal scraping + culture at initial presentation to rule out infectious etiology; ANCA, ANA, RF, anti-CCP, CBC, CMP, chest X-ray, urinalysis for systemic workup
Symptoms: Ocular pain, redness, photophobia, tearing, decreased vision; may be painless in RA patients with peripheral neuropathy — a deceptive presentation
Management: Infectious PUK → targeted antimicrobials (4th-gen fluoroquinolone empirically); Noninfectious PUK → preservative-free lubricants, oral doxycycline (anti-collagenase), Vitamin C 500-1000 mg/day (collagen synthesis support), systemic corticosteroids (prednisone), MTX or azathioprine; refractory → cyclophosphamide or rituximab; surgical → conjunctival resection, cyanoacrylate glue for impending perforation, amniotic membrane, keratoplasty (last resort)
Emergency flag: Corneal perforation from stromal melt = surgical emergency requiring emergent corneal gluing or penetrating keratoplasty (PK)
One-Sentence SummaryPeripheral ulcerative keratitis (PUK; H16.081-H16.083; Greek periphereia + keras + Latin ulcus + Greek -itis = “inflammatory ulceration of the peripheral cornea”) is an immune complex-mediated destructive crescentic corneal melt at the juxtalimbal zone most commonly driven by rheumatoid arthritis (~40%) or GPA, managed with systemic immunosuppression (M05.x/M31.30), conjunctival resection (68110), and — when corneal perforation threatens — keratoplasty (65730/65755) or amniotic membrane transplantation (65778).